In addition to its therapeutic implications, molecular analysis can integrate the diagnostic process in specific situations; for instance, the identification of a KIT or PDGFRA mutation in a suspected GIST with negative CD117 and DOG1 expressions could aid differential diagnosis [17]. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.